4.5 Article

Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever

Related references

Note: Only part of the references are listed.
Review Allergy

IL-1β Biological Treatment of Familial Mediterranean Fever

Alessandra Soriano et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2013)

Article Medicine, General & Internal

Rilonacept for Colchicine-Resistant or -Intolerant Familial Mediterranean Fever A Randomized Trial

Philip J. Hashkes et al.

ANNALS OF INTERNAL MEDICINE (2012)

Review Immunology

Incomplete response to colchicine in M694V homozygote FMF patients

Merav Lidar et al.

AUTOIMMUNITY REVIEWS (2012)

Article Medicine, General & Internal

Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

Nicolino Ruperto et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Review Rheumatology

Interleukin-1 Targeting Drugs in Familial Mediterranean Fever: A Case Series and a Review of the Literature

Ulrich Meinzer et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)

Review Immunology

Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease

Seth L. Masters et al.

ANNUAL REVIEW OF IMMUNOLOGY (2009)

Article Medicine, General & Internal

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

Helen J. Lachmann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)